2021 연구자 정보 (15 / 1141)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
---|---|---|---|---|---|---|---|---|---|---|
Kwon, Youngoh (Kwon, Y) |
GENOME INSIGHT Inc, Daejeon, South Korea |
|
|
[JCR상위 0.7%] Clonal dynamics in early human embryogenesis inferred from somatic mutation | SCIE | 0.7 | MULTIDISCIPLINARY SCIENCES |
ohjiwon@knu.ac.kr ysju@kaist.ac.kr |
||
Lee, Junehawk (Lee, J) |
Korea Inst Sci & Technol Informat KISTI, Daejeon, South Korea |
|
|
[JCR상위 0.7%] Clonal dynamics in early human embryogenesis inferred from somatic mutation | SCIE | 0.7 | MULTIDISCIPLINARY SCIENCES |
ohjiwon@knu.ac.kr ysju@kaist.ac.kr |
||
Liang, Qing (Liang, Q) |
NASA, Goddard Space Flight Ctr, Greenbelt, MD USA |
B-1276-2011 Liang, Qing |
0000-0002-8430-0515 Liang, Qing |
[JCR상위 0.7%] A decline in emissions of CFC-11 and related chemicals from eastern China | SCIE | 0.7 | MULTIDISCIPLINARY SCIENCES |
Luke.western@bristol.ac.uk rprinn@mit.edu matt.rigby@bristol.ac.uk |
||
Liau, Nicholas P. D. (Liau, NPD) |
Genentech Inc, Dept Struct Biol, San Francisco, CA 94080 USA |
HJI-9205-2023 Liau, Nicholas |
0000-0002-3887-899X Liau, Nicholas |
[JCR상위 0.7%] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma | SCIE | 0.7 | MULTIDISCIPLINARY SCIENCES |
twkimmd@amc.seoul.kr shivam@gene.com |
||
Lim, Hyeong-Seok (Lim, HS) |
Univ Ulsan, Asan Med Ctr, Dept Clin Pharmacol & Therapeut, Coll Med, Seoul, South Korea |
AAX-4732-2020 Lim, Hyeong-seok |
|
[JCR상위 0.7%] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma | SCIE | 0.7 | MULTIDISCIPLINARY SCIENCES |
twkimmd@amc.seoul.kr shivam@gene.com |
||
Lim, Joonoh (Lim, J) |
Korea Adv Inst Sci & Technol KAIST, Grad Sch Med Sci & Engn GSMSE, Daejeon, South Korea |
|
|
[JCR상위 0.7%] Clonal dynamics in early human embryogenesis inferred from somatic mutation | SCIE | 0.7 | MULTIDISCIPLINARY SCIENCES |
ohjiwon@knu.ac.kr ysju@kaist.ac.kr |
||
Lin, Eva (Lin, E) |
Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA |
|
|
[JCR상위 0.7%] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma | SCIE | 0.7 | MULTIDISCIPLINARY SCIENCES |
twkimmd@amc.seoul.kr shivam@gene.com |
||
Malek, Shiva (Malek, S) |
교신저자 | Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA |
|
|
[JCR상위 0.7%] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma | SCIE | 0.7 | MULTIDISCIPLINARY SCIENCES |
twkimmd@amc.seoul.kr shivam@gene.com |
|
Manning, Alistair J. (Manning, AJ) |
Met Off, Hadley Ctr, Exeter, Devon, England |
|
|
[JCR상위 0.7%] A decline in emissions of CFC-11 and related chemicals from eastern China | SCIE | 0.7 | MULTIDISCIPLINARY SCIENCES |
Luke.western@bristol.ac.uk rprinn@mit.edu matt.rigby@bristol.ac.uk |
||
Martin, Scott E. (Martin, SE) |
Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA |
|
|
[JCR상위 0.7%] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma | SCIE | 0.7 | MULTIDISCIPLINARY SCIENCES |
twkimmd@amc.seoul.kr shivam@gene.com |
||
Modrusan, Zora (Modrusan, Z) |
Genentech Inc, Dept Microchem Prote & Lipid, San Francisco, CA 94080 USA |
|
|
[JCR상위 0.7%] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma | SCIE | 0.7 | MULTIDISCIPLINARY SCIENCES |
twkimmd@amc.seoul.kr shivam@gene.com |
||
Montzka, Stephen A. (Montzka, SA) |
NOAA, Global Monitoring Lab, Boulder, CO USA |
V-6162-2019 montzka, stephen |
0000-0002-9396-0400 Montzka, Stephen |
[JCR상위 0.7%] A decline in emissions of CFC-11 and related chemicals from eastern China | SCIE | 0.7 | MULTIDISCIPLINARY SCIENCES |
Luke.western@bristol.ac.uk rprinn@mit.edu matt.rigby@bristol.ac.uk |
||
Moore, Amanda R. (Moore, AR) |
Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA |
|
|
[JCR상위 0.7%] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma | SCIE | 0.7 | MULTIDISCIPLINARY SCIENCES |
twkimmd@amc.seoul.kr shivam@gene.com |
||
Noh, Young Su (Noh, YS) |
Hanmi Pharmaceut Co Ltd, Dept Clin Res & Dev, Seoul, South Korea |
|
|
[JCR상위 0.7%] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma | SCIE | 0.7 | MULTIDISCIPLINARY SCIENCES |
twkimmd@amc.seoul.kr shivam@gene.com |
||
Nowicka, Malgorzata (Nowicka, M) |
Genentech Inc, Dept Oncol Biomarker Dev, San Francisco, CA 94080 USA |
|
|
[JCR상위 0.7%] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma | SCIE | 0.7 | MULTIDISCIPLINARY SCIENCES |
twkimmd@amc.seoul.kr shivam@gene.com |
페이지 이동: